Edition:
United States

Synergy Pharmaceuticals Inc (SGYP.OQ)

SGYP.OQ on NASDAQ Stock Exchange Global Select Market

2.03USD
16 Feb 2018
Change (% chg)

$-0.08 (-3.79%)
Prev Close
$2.11
Open
$2.09
Day's High
$2.10
Day's Low
$2.03
Volume
478,637
Avg. Vol
1,349,901
52-wk High
$6.45
52-wk Low
$1.68

Select another date:

Wed, Feb 14 2018

BRIEF-Paulson & Co Dissolves Share Stake In Sprint, Cuts In Synergy Pharmaceuticals ‍​

* PAULSON & CO CUTS SHARE STAKE IN SYNERGY PHARMACEUTICALS TO 4 MILLION SHARES FROM 24.1 MILLION SHARES - SEC FILING

BRIEF-Synergy Pharma Meets Cash Balance Requirement

* SYNERGY PHARMACEUTICALS SAYS HAS MET CASH BALANCE REQUIREMENT TO ACCESS ADDITIONAL CAPITAL UNDER TERM LOAN AGREEMENT DATED SEPT 1, 2017 Source text for Eikon: Further company coverage:

BRIEF-Synergy Pharmaceuticals Announces FDA Approval Of TRULANCE

* SYNERGY PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF TRULANCE® (PLECANATIDE) FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) IN ADULTS

BRIEF-Synergy Pharmaceuticals Appoints Troy Hamilton Chief Executive Officer

* SYNERGY PHARMACEUTICALS APPOINTS TROY HAMILTON CHIEF EXECUTIVE OFFICER

BRIEF-CVI Investments reports a 7.9 pct passive stake in Synergy Pharmaceuticals as of Nov 13, 2017

* CVI Investments Inc reports a 7.9 percent passive stake in Synergy Pharmaceuticals Inc as of November 13, 2017 - SEC Filing‍​ Source text: (http://bit.ly/2A4qbNI) Further company coverage:

BRIEF-Synergy Pharma announces pricing of offering of common stock and warrants

* Synergy Pharmaceuticals announces pricing of offering of common stock and warrants

BRIEF-Synergy Pharma files for a potential mixed shelf offering ‍​

* Synergy Pharmaceuticals Inc files for a potential mixed shelf offering; size undisclosed - SEC filing ‍​ Source text: (http://bit.ly/2mihpZ2) Further company coverage:

BRIEF-Synergy Pharmaceuticals posts Q3 loss per share $0.22

* Synergy Pharmaceuticals reports third quarter 2017 financial results and business update

BRIEF-Synergy Pharmaceuticals secures $300 mln debt financing

* Synergy Pharmaceuticals secures $300 million debt financing

Select another date: